In global developments, European officials warn of a growing gap in vaccine coverage, and the WHO certifies measles and rubella elimination in Bahrain, Oman, and Iran.
Brown KE, Rota PA, Goodson JL, et al. Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance. MMWR 2019 Jul 5;68(26):587-91
Choe SA, Cho YJ, Paek JY. Rubella seroepidemiology among Korean women: two decades after combined vaccination strategy. Int J Infect Dis 2020 (published online Feb 26)
Grant GB, Desai S, Dumolard K, et al. Progress toward rubella and congenital rubella syndrome control and elimination — worldwide, 2000-2018. MMWR 2019 Oct 4;68(39):855-9
Khetsuriani N, Chitadze N, Russell S, et al. Measles and rubella seroprevalence among adults in Georgia in 2015: helping guide the elimination efforts. Epidemiol Infect 2019 (published online Dec 11)
Mazaba ML, Siziya S, Monze M, et al. Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005-2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era. BMC Infect Dis 2020 Feb 3;20:180
Murhekar M, Verma S, Singh K, et al. Epidemiology of congenital rubella syndrome (CRS) in India, 2016-18, based on data from sentinel surveillance. PLOS Negl Trop Dis 2020 Feb 3;14(2):e0007982
Taku NA, Ndze VN, Abernathy E, et al. Seroprevalence of rubella virus antibodies among pregnant women in the center and south-west regions of Cameroon. PLOS One 2019 Nov 21;14(11):e0225594
Woyessa AB, Ali MS, Korkpor TK, et al. Rubella transmission and the risk of congenital rubella syndrome in Liberia: a need to introduce rubella-containing vaccine in the routine immunization program. BMC Infect Dis 2019 Sep 18;19:813
